Concepedia

Leopold Öhler

LÖ

22

Publications

1.1K

Citations

15

H-Index

1993

Active since

Affiliations

Medical University of Vienna(Current)

University of Vienna

Medical University of Graz

Universität Innsbruck

Innsbruck Medical University

Leopold Öhler is an author at Medical University of Vienna specializing in medicine, pathology, and hematology.

Top concepts

Publications per year

1993–2025

22

Publications

22

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

, , +7

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders

Christoph Kornauth, Tea Pemovska, Gregory I. Vladimer et al. · Cancer Discovery · 2021 · 196 citations · Full text

Safety and effectiveness of regorafenib in patients with metastatic colorectal cancer in routine clinical practice in the prospective, observational CORRELATE study

Michel Ducreux, Lone Nørgård Pétersen, Leopold Öhler et al. · European Journal of Cancer · 2019 · 75 citations · Full text

Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells.

Leopold Öhler, Manuela Födinger, Irene Virgolini et al. · The Journal of Experimental Medicine · 1996 · 65 citations · Full text

, , +18

Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?

Ursula Vogl, Haleh Andalibi, Alexander Klaus et al. · BMC Cancer · 2019 · 54 citations · Full text

Rows per page

1–5 of 22